Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 10, 2018
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
May 10, 2018
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
CRANBURY, N.J., May 10, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2018 operating results on Tuesday, May ...
May 10, 2018
Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements
HOUSTON and VANCOUVER , May 10, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, Nasdaq: EPIX), a pre-clinical stage pharmaceutical company ...
May 9, 2018
Lipocine Receives Complete Response Letter for TLANDO From U.S. Food and Drug Administration
SALT LAKE CITY, May 9, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that it has received a Complete Response Letter ("CRL") ...
May 9, 2018
Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15
REHOVOT, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that it will release financial results ...
May 9, 2018
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results
TEL AVIV, Israel, May 9, 2018 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
May 9, 2018
ProQR Announces Results for the First Quarter of 2018
LEIDEN, the Netherlands, May 09, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
May 9, 2018
Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 9, 2018
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts
CRANBURY, N.J., May 9, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
May 9, 2018
Krystal Biotech Presents In Vivo KB103 Data at the International Investigative Dermatology Conference that Show Human COL7 Incorporating into Anchoring Fibrils with Proper Structural Orientation
PITTSBURGH, May 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal “off-the-shelf” treatments for rare dermatological ...
May 9, 2018
CorMedix Inc. to Report First Quarter 2018 Financial Results on Tuesday, May 15
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 9, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
May 9, 2018
Aimmune Therapeutics to Participate in Four Upcoming Investor Conferences in May and June
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of the Aimmune executive management team ...
May 9, 2018
PolarityTE™ Accelerates Sales Team for Targeted Regional Release of SkinTE™
SALT LAKE CITY, May 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) announced today that it is growing its commercial presence by hiring dedicated sales ...
May 9, 2018
MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for Afrezza® in India
WESTLAKE VILLAGE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), a company focused on the development and commercialization of inhaled therapeutic products for ...
May 9, 2018
Zogenix Provides Corporate Update and Reports First Quarter Financial Results
EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
May 9, 2018
MannKind Corporation Reports 2018 First Quarter Financial Results
WESTLAKE VILLAGE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today reported financial results for the first quarter ended March 31, 2018. ...
May 9, 2018
Aileron Therapeutics Reports First Quarter 2018 Financial Results
CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other ...
May 9, 2018
TRACON Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 8, 2018
Moberg Pharma AB Interim Report January - March 2018
STOCKHOLM, May 8, 2018 /PRNewswire/ -- SIGNIFICANT GROWTH FOR ALL KEY BRANDS FIRST QUARTER (JAN-MAR 2018) Net revenue SEK 91.5 million (104.6) EBITDA SEK 21.9 ...
May 8, 2018
Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin ) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product
FORT LEE, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Kedrion Biopharma and Kamada Ltd. (KMDA) (KMDA.TA), two leading human-derived protein therapeutics companies, announced today that KEDRAB® [Rabies Immune ...
Page 53 of 127